New implant aims to tame hard-to-treat seizures
NCT ID NCT07640191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the iVEAcare Neuromodulation System for people with drug-resistant epilepsy, whose seizures are not controlled by medication. About 30 participants will receive the implant and be followed for up to 5 years. Researchers will check for side effects and measure whether the device reduces seizure frequency and severity and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- LIFU for Drug-Resistant Epilepsy Trial NCT07680842
- Fluorescence Guided FCD Surgery Trial (NCT07657975)
- Epileptogenic Network MRI Study NCT06059157
- Cannabinoids for Drug Resistant Epilepsy Trial (NCT07023744)
- Leucine Amino Acid for Refractory Epilepsy NCT06387186
- NaviFUS Ultrasound for Drug-Resistant Epilepsy (NCT06492720)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••